Clinical Trials

Showing trials with last updates posted in 2026.

NCT05803382 | RECRUITING | PHASE1
30 participants

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2023-11-08
Completion:
2027-06-30
Conditions
  • Metastatic Colorectal Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Stage IV Colorectal Cancer AJCC v8
  • Unresectable Colorectal Carcinoma
  • Unresectable Malignant Solid Neoplasm
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT05797246 | ACTIVE_NOT_RECRUITING | PHASE2
21 participants

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2023-08-02
Completion:
2027-07-31
Conditions
  • Respiratory Tract Diseases
  • Neoplasms
  • Neoplasms by Histologic Type
  • Neoplasms, Glandular and Epithelial
  • Neoplasms, Squamous Cell
  • Tumor Virus Infections
  • Infections
  • Virus Diseases
  • DNA Virus Infections
  • Pathologic Processes
  • Disease Attributes
  • Recurrence
  • Papilloma
  • Respiratory Tract Infections
  • Papillomavirus Infections
Interventions
  • DRUG
No Results Yet
NCT05773274 | RECRUITING | PHASE2
100 participants

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2024-01-12
Completion:
2029-04-30
Conditions
  • Metastatic Digestive System Neuroendocrine Tumor G1
  • Metastatic Digestive System Neuroendocrine Tumor G2
  • Unresectable Digestive System Neuroendocrine Tumor G1
  • Unresectable Digestive System Neuroendocrine Tumor G2
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
NCT05772546 | COMPLETED | PHASE2
49 participants

Avatrombopag vs. Placebo for CIT in GI Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2023-11-01
Completion:
2026-01-02
Conditions
  • Gastrointestinal Cancer
  • Gastrointestinal Neoplasms
  • Chemotherapy-Induced Thrombocytopenia
Interventions
  • DRUG
No Results Yet
NCT05756166 | TERMINATED | PHASE1/PHASE2
5 participants

Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2024-02-16
Completion:
2025-04-08
Conditions
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Carcinoma
  • Unresectable Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
NCT05652270 | ACTIVE_NOT_RECRUITING | NA
258 participants

Maximizing Patient Goal Attainment

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2023-05-30
Completion:
2026-11-30
Conditions
  • Knee Osteoarthritis
  • Knee Injuries
  • Knee Pain Chronic
  • Knee Injuries and Disorders
Interventions
  • BEHAVIORAL
No Results Yet
NCT05642195 | SUSPENDED | PHASE1/PHASE2
30 participants

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2026-09-03
Completion:
2033-12-30
Conditions
  • Non-Small Cell Lung Cancer
  • Non-Small Cell Lung Carcinoma
  • Carcinoma, Non-Small-Cell Lung
  • Carcinomas
Interventions
  • BIOLOGICAL
  • DRUG
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page